Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2000040005Phase 4Not yet recruiting
Phase 4, randomised trial of propofol in perioperative neurocognitive disorder (3 arms), sponsored by The First Affiliated Hospital of University of Science and Technology of China. Primary endpoints: Mini-Mental State Examination (MMSE) and Montreal Cognitive Assessment (MoCA). Planned start May 2021; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2000040005.